MedTrace Logo

Study of a New Dressing for Use With Topical Medications

NCT00234728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2008-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine if a new dressing designed to be used with topical medications will enhance the effects of these topical medications.

Conditions

Interventions

DEVICE

Occlusive dressing

Sponsors & Collaborators

  • Teikoku Pharma USA, Inc.

    lead INDUSTRY

Principal Investigators

  • John Koo, MD · University of California, San Francisco

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00234728 on ClinicalTrials.gov